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a b s t r a c t
Monosodium glutamate (MSG) is a neuroexcitatory amino acid commonly used as ﬂavoring of foods.
MSG neonatal administration to animals leads to behavioral and physiological disorders in adulthood,
including increased pain sensitivity. This study aimed to investigate the effect of diphenyl diselenide
(PhSe)2, an organoselenium compound with pharmacological properties already documented, on
nociception induced by MSG. Newborn Wistar rats received 10 subcutaneous injections of MSG at a
dose of 4.0 g/kg or saline (once daily). At the 60th day of life, the rats were daily treated with (PhSe)2
(1 mg/kg) or vehicle (canola oil) by the intragastric route for 7 days. The behavioral tests (locomotor
activity, hot plate, tail-immersion and mechanical allodynia) were carried out. Ex vivo assays were
performed in samples of hippocampus to determine Naþ , Kþ-ATPase and Ca2þ-ATPase activities,
cytokine levels and [3H]glutamate uptake. The results demonstrated that MSG increased nociception in
the hot plate test and in the mechanical allodynia stimulated by Von-Frey hair but did not alter the tail
immersion test. (PhSe)2 reversed all nociceptive behaviors altered by MSG. MSG caused an increase in
Naþ ,Kþ-ATPase and Ca2þ-ATPase activities and in pro-inﬂammatory cytokine levels and a decrease in
the anti-inﬂammatory cytokine and in the [3H]glutamate uptake. (PhSe)2 was effective in reversing all
alterations caused by MSG. The results indicate that (PhSe)2 had a potential antinociceptive and anti-
inﬂammatory action in the MSG model.
& 2015 Elsevier B.V. All rights reserved.
1. Introduction
The human diet has changed greatly during the past decades
and with this the introduction of industrialized foods in diet of
children widely increased, because processed foods are more
palatable by the use of food additives to preserve ﬂavor and
enhance taste. One of the most commonly consumed food addi-
tives is monosodium glutamate (MSG), a neuroexcitatory amino
acid used as a ﬂavoring agent (McCabe and Rolls, 2007).
Earlier studies have demonstrated that MSG has some adverse
effects in humans and experimental animals. In rodents, the
administration of high doses of MSG during early stages of brain
development induces destruction of sites in the hypothalamus (Abe
et al., 1990), which causes neuroendocrine abnormalities. These
abnormalities can result in animal functional and behavioral dis-
orders in adulthood, including obesity, hyperexcitability, impairment
of memory, anxiogenic-like and depressive-like behaviors, pain-
sensitivity and changes in analgesic responses (Badillo-Martinez
et al., 1984; Collison et al., 2010; Lopez-Perez et al., 2010; Quines
et al., 2014; van den Buuse et al., 1985).
Even though little is known about the mechanism of action by
which MSG induces nociception, studies have demonstrated that
neonatal exposure to MSG leads to degeneration in hippocampal
CA1 pyramidal cells (Beas-Zarate et al., 2002; Ishikawa et al., 1997).
In addition, previous studies indicate that the hippocampal forma-
tion is involved in emergence of nociception (Klamt and Prado,
1991; Mckenna and Melzack, 1992) as well as the intensity of
nociceptive stimulation is positively related to amplitude of excita-
tory postsynaptic potentials in hippocampal CA1 pyramidal cells
(Wei et al., 2000). Thus, studies focus on the involvement of
hippocampus in the nociception induced by MSG and the search
for compounds which are effective in blocking nociceptive signaling
pathways implicated in this process are of great importance.
Organoselenium compounds have roused interest due to their
pharmacological activities (Nogueira et al., 2004). Besides their
antioxidant action (Bortolatto et al., 2013; Bruning et al., 2012) these
compounds have shown to have neuroprotective (Abdel-Hafez and
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Abdel-Wahab, 2008), anti-inﬂammatory and antinociceptive proper-
ties (Chagas et al., 2014; Marcondes Sari et al., 2014). Diphenyl
diselenide (PhSe)2 is an organoselenium compound that has been
documented as an attractive candidate for therapeutic agent in
experimental models of nociception and inﬂammation (da Rocha
et al., 2013a; Luchese et al., 2012). The mechanism of action by which
(PhSe)2 elicits the antinociceptive action involves the modulation of
serotonergic, nitrergic and glutamatergic systems (Savegnago et al.,
2007b; Zasso et al., 2005). Regarding the pharmacokinetic properties,
(PhSe)2 shows a wide tissue distribution proﬁle in rodents (Prigol
et al., 2012).
Considering what was mentioned before, the present study was
designed to investigate the effect of (PhSe)2 on nociception
induced by MSG in rats. We also investigated the possible
mechanisms of action by which (PhSe)2 causes antinociception.
2. Materials and methods
2.1. Animals
The experiments were carried out using newborn Wistar rats
from our own breeding colony. The animals were kept in a separate
animal room, on a 12 h light/dark cycle; the lights were turned on
every day at 7:00 a.m., at room temperature (2271 1C) with free
access to water and food. The experiments were performed accord-
ing to the guidelines of the Committee on Care and Use of Experi-
mental Animal Resources, the Federal University of Santa Maria,
(#027/2014). All efforts were made to minimize animal suffering and
to reduce the number of animals used in the experiments.
2.2. Drugs
Diphenyl diselenide (PhSe)2 (Fig. 1) was prepared in our
laboratory according to a previous described method (Paulmier,
1986). The chemical purity (99.9%) was determined by gas chro-
matography–mass spectrometry (GC/MS). Analysis of 1H and 13C
Nuclear Magnetic Resonance Spectroscopy showed analytical and
spectroscopic data in full agreement with its assigned structure.
(PhSe)2 was diluted in canola oil.
Monosodium glutamate (MSG) was purchased from Sigma-
Aldrich (St. Louis, MO, USA). All other chemicals were of analytical
grade and obtained from standard commercial suppliers.
2.3. Experimental design
The newborn Wistar rats received 10 subcutaneous injections
of MSG at a dose of 4.0 g/kg or saline (0.9%) in a similar volume
(1 ml/kg), once a day starting at the ﬁrst postnatal day (Klingberg et
al., 1987). The pups were weaned at the 21st day of life. At the 60th
day of life, the female rats were divided into four groups. MSG and
saline groups were treated with (PhSe)2 (1 mg/kg) or vehicle
(canola oil, 1 ml/kg) by the intragastric (i.g.) route once a day for
7 days. Thirty minutes after the last treatment with (PhSe)2, the
animals were submitted to the locomotor activity monitor and
nociceptive tests (hot plate, tail-immersion and mechanical allody-
nia). Behavioral tests were carried out after 30 min of the last
treatment with (PhSe)2 by different groups of animals following the
order; locomotor activity and one of the nociceptive tests for each
group of animals. Immediately after the nociceptive test, rats were
killed by cervical dislocation and hippocampi, a target structure for
neonatal MSG action (Beas-Zarate et al., 2002), were excised from
the brain and frozen (80 1C) to perform the ex vivo assays.
Repeated treatment with a dose of 1 mg/kg was chosen based on
the fact that this is a sub-effective antinociceptive dose of (PhSe)2 in
an acute nociceptive model in rats (Da Rocha et al., 2013b). The
7 days regimen of (PhSe)2 administration was selected based on a
previous pharmacological study (Bortolatto et al., 2015).
2.4. Behavioral tests
2.4.1. Spontaneous locomotor activity
With the purpose of excluding sedative or motor abnormality,
spontaneous locomotor activity of rats was performed in the
locomotor activity monitor. The locomotor activity monitor is a
Plexiglas box (45 cm45 cm45 cm) surrounded by a frame con-
sisting of 32 photocells mounted on opposite walls (16 L16W,
spaced 2 cm apart) that continuously tracks the animal's movement.
Animals were placed in the center of the apparatus and allowed to
freely explore the arena during 4 min. Motor activity was monitored
with the InsightsMonitor Activity System and the rat position in the
chamber is detected by breaks of the photocell beams. The number of
crossings and rearings, average velocity (mm/s) and total distance
traveled (dm) were recorded.
2.4.2. Hot plate test
The hot-plate test was carried out according to the method
described previously (Woolfe and MacDonald, 1944). In this test, the
animals were placed in a glass cylinder on a heated metal plate
maintained at 557 1 1C. The latency of nociceptive responses, such
as licking or shaking one of the paws or jumping, was recorded as
the reaction time. In order to avoid damage to the paws of the
animals, the time standing on the plate was limited to 60 s.
2.4.3. Tail-immersion test
The tail-immersion test was conducted as described previously
(Janssen et al., 1963). The test was performed by immersing the
lower 3.5 cm of the tail into a cup freshly ﬁlled with water from a
large constant-temperature (55 1C) bath until the typical tail
withdrawal response was observed. A 7 s cut-off was imposed.
2.4.4. Mechanical allodynia test
The mechanical allodynia was measured as described before
(Bortalanza et al., 2002). Rats were further acclimatized in indivi-
dual clear Plexiglas boxes (9 cm7 cm11 cm) on an elevated
wire mesh platform to allow access to the ventral surface of the
hind paw. The withdrawal response frequency of the left hind paw
was measured following 10 applications (duration of 1–2 s each) of
2 g Von Frey hairs (VFH; Stoelting, Chicago, IL, USA).
2.5. Ex vivo assays
2.5.1. Tissue preparation
The hippocampus samples of all animals were homogenized in
50 mM Tris/HCl at pH 7.4. The homogenate was centrifuged at
2.500 g for 10 min at 4 1C to yield a low-speed supernatant
fraction (S1). Freshly prepared S1 was used for the determination
of Naþ , Kþ-ATPase and Ca2þ-ATPase activities and for the mea-
surement of cytokine levels.Fig. 1. Chemical structure of diphenyl diselenide (PhSe)2.
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2.5.2. [3H]Glutamate uptake assay
The [3H]glutamate uptake assay was carried out in slices
(0.4 mm) of hippocampus using a McIllwain chopper. The gluta-
mate uptake was performed according to the method described by
Thomazi et al. (2004). The slices were transferred to multiwell
dishes and washed with 1.0 ml Hank's buffered salt solution (HBSS).
After 10 min of pre-incubation, the uptake assay was performed by
adding 13.3 μM [3H]glutamate in 300 μl HBSS at 37 1C. Incubation
was terminated after 5 min by three ice-cold washes with 1 ml
HBSS immediately followed by the addition of 0.5 M NaOH, which
was kept overnight. An aliquot of 10 μl was removed to protein
determination. Unspeciﬁc uptake was measured using the same
protocol described above, with differences in the temperature (4 1C)
and medium composition (choline chloride instead of sodium
chloride). Naþ-dependent uptake was considered as the difference
between the total uptake and the unspeciﬁc uptake. Both uptakes
were performed in triplicate. Incorporated radioactivity was mea-
sured using a liquid scintillation counter. Results were expressed as
pmol of [3H]glutamate uptake/mg protein/min.
2.5.3. Naþ , Kþ-ATPase activity
The Naþ , Kþ-ATPase activity was measured according to a
method described previously (Wyse et al., 2000). An aliquot of S1
was added to the reaction mixture for Naþ , Kþ-ATPase activity
assay containing 3 mM MgCl, 125 mM NaCl, 20 mM KCl and
50 mM Tris–HCl, pH 7.4, in a ﬁnal volume of 500 μl. The reaction
was initiated by the addition of ATP to a ﬁnal concentration of
3.0 mM. Control samples were carried out under the same condi-
tions with the addition of 0.1 mM ouabain. The samples were
incubated for 30 min at 37 1C, and the incubation was stopped by
adding trichloroacetic acid solution (10% TCA) with 10 mM HgCl2.
The Naþ , Kþ-ATPase activity was calculated by the difference
between the two assays. Released inorganic phosphate (Pi) was
measured by the method of Fiske and Subbarow (1925). The
enzymatic activity was expressed as nmol Pi/min/mg protein.
2.5.4. Ca2þ-ATPase activity
The Ca2þ-ATPase activity was measured as previously described
by Rohn et al. (1993) with minor modiﬁcations (Trevisan et al.,
2009). Brieﬂy, the assay medium consisted of 30 mM Tris–HCl
buffer (pH 7.4), 0.1 mM EGTA, 3 mM MgCl2 and 100 μg of protein
in the presence or absence of 0.4 mM CaCl2, in a ﬁnal volume of
200 μl. The reaction was initiated by the addition of ATP to a ﬁnal
concentration of 3.0 mM. After incubation for 60 min at 37 1C, the
reaction was stopped by adding 50% TCA solution. The released
inorganic phosphate (Pi) was measured by the method of Fiske and
Subbarow (1925). The Ca2þ-ATPase activity was calculated by
subtracting the activity measured in the presence of Ca2þ from
that determined in the absence of Ca2þ ( no added Ca2þ plus
0.1 mM EGTA). The enzymatic activity was expressed as nmol
Pi/min/mg protein.
2.5.5. Determination of cytokines
The levels of IL-1, IL-6, TNFα, INFγ and IL-10 in S1 were
measured using commercial ELISA kits for rat as described by
the manufacturer (eBIOSCIENCEs, San Diego, USA). The results are
expressed in pg/mg of protein.
2.5.6. Protein determination
The protein concentration was measured by the Coomassie
blue method according to Bradford (1976) using bovine serum
albumin (1 mg/ml) as a standard.
2.6. Statistical analysis
The normality of data was analyzed using a D'Agostino and
Pearson omnibus normality test. Data were analyzed by the two-
way analysis of variance (ANOVA) followed by the Newman–Keuls
test. All data of experiments were expressed as means7S.E.M.
Probability P values less than 0.05 (Po0.05) were considered as
statistically signiﬁcant.
3. Results
3.1. Behavioral tests
3.1.1. Spontaneous locomotor activity
The spontaneous locomotor activity was measured to discard
non-speciﬁc effects of treatments in the behavioral tests. Neither
the injection of MSG nor (PhSe)2 treatment altered the number of
crossings and rearings, velocity and the total distance traveled
(P40.05) by rats in the locomotor activity monitor (Table 1).
3.1.2. Hot-plate test
The hot-plate test was used to evaluate the effects of treatments
in thermal hyperalgesia. The two-way ANOVA of hot-plate data
revealed a signiﬁcant MSG (PhSe)2 interaction (F1,27¼23.2061,
Po0.001). The administration of MSG to rats decreased the
response latency to thermal stimuli as compared with that of the
saline group (Po0.001). (PhSe)2 caused a signiﬁcant blocked of
thermal hyperalgesia induced by MSG in rats (Po0.001) (Fig. 2A).
3.1.3. Tail immersion test
We carried out the tail immersion test, a test that involves
spinal reﬂex, to further investigate the effects of treatments in
thermal hyperalgesia. The results of Fig. 2B showed a signiﬁcant
main effect of (PhSe)2 in the tail immersion test (F1,25¼14.0488,
Po0.001). Although the subcutaneous injection of MSG did not
change the tail-immersion response latency, the animals exposed
to MSG and treated with (PhSe)2 had an increase in the tail
withdrawal response compared with those of the saline group
(Po0.01).
3.1.4. Mechanical allodynia test
Given that (PhSe)2 reversed thermal hyperalgesia induced by MSG
in rats, the effects of MSG and (PhSe)2 were investigated in mechanical
allodynia. The two-way ANOVA of mechanical allodynia data dem-
onstrated a signiﬁcant MSG (PhSe)2 interaction (F1,24¼14.0713, Po
0.001). Post hoc analyses indicated a signiﬁcant increase in the
Table 1
Effect of (PhSe)2-treatment on spontaneous locomotor activity of rats that received subcutaneous MSG administration.
Locomotor parameters Saline MSG (PhSe)2 MSGþ(PhSe)2
Number of crossing 881.47119.1 786.07114.5 1137.57113.6 918.57127.6
Number of rearing 26.572.88 29.775.44 27.777.19 28.074.19
Velocity (mm/s) 27.674.22 28.473.46 30.174.16 27.572.32
Distance (mm) 5813.971007,8 5608.87753.2 7063.071017.8 5800.67605.5
Values are reported as means7S.E.M. for seven animals per group. Data were analyzed by using a two-way analysis of variance (ANOVA).
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mechanical sensitivity on the left hind paws of rats administered with
MSG when compared with those of the saline group (Po0.001).
Treatment with (PhSe)2 was effective in decreasing the mechanical
allodynia induced by MSG injection (Po0.001) (Fig. 3).
3.2. Ex vivo assays
3.2.1. [3h]Glutamate uptake assay
The [3H] glutamate uptake assay was carried out to investigate
whether the antinociceptive action of (PhSe)2 was related to an
increase in glutamate within the hippocampus. The two-way ANOVA
of [3H]glutamate uptake data revealed a signiﬁcant MSG (PhSe)2
interaction (F1,8¼35.6137, Po0.001). Post hoc analyses indicated a
signiﬁcant decrease in [3H]glutamate uptake by MSG and (PhSe)2
groups when compared with that of the saline group (Po0.05).
Treatment with (PhSe)2 was effective to reverse the decrease in [3H]
glutamate uptake caused by MSG (Po0.01) (Fig. 4).
3.2.2. Naþ , Kþ-ATPase activity
Deactivation of glutamatergic signaling in the brain is mediated
by glutamate transporters, which rely indirectly on Naþ , Kþ-ATPase
to generate ion gradients that drive transmitter uptake (Rose et al.,
2009b). Naþ , Kþ-ATPase activity was determined to further inves-
tigate events involved in glutamate uptake. The two-way ANOVA of
hippocampal Naþ , Kþ-ATPase activity data revealed a signiﬁcant
MSG (PhSe)2 interaction (F1,16¼5.440, Po0.05). Post hoc compar-
isons demonstrated an increase in Naþ , Kþ-ATPase activity induced
by MSG administration when compared with that of the saline
group (Po0.05). (PhSe)2 totally reversed the increase in Naþ , Kþ-
ATPase activity caused by MSG (Po0.01) (Fig. 5).
3.2.3. Ca2þ-ATPase activity
Ca2þ-ATPase is an enzyme important to control excitotoxicity,
contributing to control of Ca2þ levels, key ion of excitotoxic events
(Chen and Lipton, 2006). The two-way ANOVA of Ca2þ-ATPase
activity data revealed a signiﬁcant MSG (PhSe)2 interaction
(F1,18¼5.009, Po0.05) (Fig. 6). Post hoc analysis showed a sig-
niﬁcant stimulation of Ca2þþ-ATPase activity in hippocampi of
rats exposed to MSG (Po0.05) when compared with that of the
saline group. (PhSe)2 treatment was effective against the increase
in Ca2þ-ATPase activity caused by MSG (Po0.05).
3.2.4. Determination of cytokines
The levels of inﬂammatory cytokines in the hippocampus were
determined because the relationship between excitotoxicity and
Fig. 2. Effect of subcutaneous MSG-injection and intragastric treatment with
(PhSe)2 on the response latency to thermal stimuli in the hot plate test (A) and
the tail immersion test (B). Data are reported as the means7S.E.M for seven to
nine animals per group. nnPo0.01, nnnPo0.001 when compared with the saline
group; ##Po0.01, ###Po0.001 when compared to the MSG group (two-way
ANOVA followed by the Newman–Keuls test).
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Fig. 3. Effect of subcutaneous MSG-injection and intragastric treatment with
(PhSe)2 on the percent response to mechanical stimulation in the left hind paw
with 2 g of Von Frey hair ﬁlaments. Data are reported as the means7S.E.M for six
to eight animals per group. nnnPo0.001 when compared with the saline group;
###Po0.001 when compared with the MSG group (two-way ANOVA followed by
the Newman–Keuls test).
Fig. 4. Effect of subcutaneous MSG-injection and intragastric treatment with
(PhSe)2 on [3H]glutamate uptake levels in hippocampus slices of rats. Data are
reported as the means7S.E.M for three animals per group. nPo0.05 when
compared with the saline group; ##Po0.01 when compared with the MSG group
(two-way ANOVA followed by the Newman–Keuls test).
Fig. 5. Effect of subcutaneous MSG-injection and intragastric treatment with
(PhSe)2 on Naþ , Kþ-ATPase activity in rat hippocampal homogenates. Results are
expressed as nanomole Pi per milligram of protein per minute. Data are reported as
the means7S.E.M for four to six animals per group. nPo0.05 when compared with
the saline group; ##Po0.01 when compared with the MSG group (two-way ANOVA
followed by the Newman–Keuls test).
S.G. Rosa et al. / European Journal of Pharmacology 758 (2015) 64–71 67
inﬂammation has been demonstrated (Julius and Basbaum, 2001;
Pocock and Kettenmann, 2007). The two-way ANOVA of the pro-
inﬂammatory cytokine levels demonstrated a signiﬁcant MSG
(PhSe)2 interaction for IL-1β, IL-6, TNFα and INFγ (F1,12¼9.584,
Po0.01; F1,11¼7.780, Po0.05; F1,12¼5.475, Po0.05; F1,12¼10.622,
Po0.01, respectively). Post hoc comparisons revealed an increase in
the levels of all pro-inﬂammatory cytokines in hippocampus of
animals that received MSG (Po0.001) when compared with those
of the saline group. Treatment with (PhSe)2 was effective against
the increase in cytokine levels induced by MSG (Po0.01). Two-way
ANOVA demonstrated a main effect of MSG in IL-10 levels
(F1,12¼7.411, Po0.05). The MSG administrations to rats signiﬁcantly
decreased IL-10 levels (Po0.05) when compared with those of the
saline group. Treatment with (PhSe)2 resulted in a tendency (but
not statistically signiﬁcant) to increase cytokine anti-inﬂammatory
(IL-10) levels in rats treated with MSG (P¼0.07) (Fig. 7).
4. Discussion
In the present study, we investigated the effect of (PhSe)2 on
nociception induced by the neonatal administration of MSG in
rats. The results demonstrated that the MSG administration to
newborn rats reduced the thermal withdrawal latency in the hot
plate test, but not in the tail immersion test, and increased the
response frequency of VFH stimulation.
Tail-immersion is regarded as a spinal reﬂex, but the mechan-
ism of response could also involve higher brain structures (Jensen
and Yaksh, 1986), while the hot-plate test produces supraspinally
integrated behavioral responses (Chapman et al., 1985). In addi-
tion, mechanical hypersensitivity is stimulated by traditional
methods such as Von-Frey hairs. Mechanical allodynia is deﬁned
as a pain sensation generated by physiological stimulation of low-
threshold sensitive and occurs due to changes of central proces-
sing of impulse activity in primary afferent neurons which feed
into central nociceptive pathways (Lambert et al., 2009). Consider-
ing that MSG treatment altered mechanical allodynia and the
withdrawal latency in the hot plate, but did not change the
response latency in tail immersion test, nociception induced by
MSG seems to involve supraspinal reﬂexes rather than spinal ones.
Additionally, the present results conﬁrm the literature data
which indicate that the antinociceptive action of (PhSe)2 is
mediated by both reﬂex types (Da Rocha et al., 2013b). Studies
from our research group also demonstrate that (PhSe)2 elicits
antinociception in different pain models in rodents (Da Rocha
et al., 2013b; Nogueira et al., 2003; Savegnago et al., 2007a; Zasso
et al., 2005). The mechanisms of action by which (PhSe)2 has the
antinociceptive action depend on its selective interaction with
N-methyl–D-aspartate receptors (NMDA) besides its interaction
with peptidergic, vanilloid and adenosine A2B receptors as well as
pro-inﬂammatory cytokines, nitric oxide synthesis and the sero-
tonergic system (Savegnago et al., 2007b; Zasso et al., 2005).
Nociception involves different structures through the interaction
between anatomical and neurophysiological pathways. Studies have
demonstrated that the cerebral cortex, thalamus and periaqueductal
gray play an important role in process of pain (Davis et al., 1998;
Tracey et al., 2002). The involvement of hippocampus in pain
processing has been reported in a number of experimental studies
and clinical observations in humans (Derbyshire et al., 1997; Hebben
et al., 1985; Khanna and Sinclair, 1992; Ploghaus et al., 2001) further
indicating that the hippocampus contributes not only to processes of
learning, memory, energy-intake regulation and reward but also in
pain related mechanisms (Erfanparast et al., 2010; Karami et al.,
2002; Kenney and Gould, 2008; Khanna et al., 2004).
We showed in the present study that rats administered with
MSG in the neonatal period had an increase in pain sensitivity
when adulthood. The exposure to high concentrations of MSG
early in life leads to excessive activation of glutamate receptors,
which induces both cell death and changes in the cytoarchitecture
of the surviving pyramidal neurons of the hippocampal CA1 ﬁeld
(Beas-Zarate et al., 2002). Corroborating this idea, Al Amin et al.
(2004) demonstrated that neonatal hippocampal lesion in rats
increased the nociceptive sensitivity in adulthood. The fact that
the nociceptive stimulus induced by glutamate activates the
hippocampal pERK1/2 molecules in supraspinal nociceptive pro-
cessing (Seo et al., 2008) and that injections of MK-801 to the
hippocampus produces an analgesic effect (Mckenna and Melzack,
1992) helps to explain how a neonatal injection of MSG leads
changes in the glutamatergic neurotransmission within the hip-
pocampus 60 days after.
Glutamate is a critical neurotransmitter for excitatory synaptic
transmission and for the generation and maintenance of pain
hypersensitivity via activation of glutamate receptors (Basbaum
et al., 2009). The mechanisms responsible for the increase of
extracellular glutamate levels include enhanced release of gluta-
mate and the reduction of glutamate uptake (Gilgun-Sherki et al.,
2002). The results showed, to the best of our knowledge for the
ﬁrst time, a decrease in the [3H]glutamate uptake in hippocampi of
rats administered with MSG in the early life, which could account
for the accumulation of glutamate within the hippocampus and
consequently cause excitotoxicity. Assuming this hypothesis, the
increase of glutamate within the hippocampus could be related to
the nociception caused by MSG in rats of 60 days. In support of this
possibility researchers have found evidence that high glutamate
concentrations can lead to changes in the expression of NMDAR
subunits (Hu et al., 1998), which mediate pain response (Bennett,
2000; Zhou et al., 1996). Corroborating these data, studies have
shown an increase in the gene expression of NMDAR subunits in
hippocampus of rats of 60 days administered with MSG neonatal
(Beas-Zarate et al., 2001, 2002).
In addition, (PhSe)2 reversed the decrease of [3H]glutamate
uptake caused by MSG, suggesting that regulation of glutamate
uptake contributes to the antinociceptive action of this compound.
Accordingly, an interaction with the glutamatergic system is one of
the mechanisms by which (PhSe)2 has antinociceptive action in
models of nociception (Savegnago et al., 2007c).
The increase of extracellular glutamate involves sustained
elevations of intracellular calcium (Ca2þ) levels through glutamate
transporters, leading to an imbalance of sodium ions across
plasma membranes (Gilgun-Sherki et al., 2002). Glutamate trans-
porters are sodium-dependent proteins that putatively rely indir-
ectly in Naþ , Kþ-ATPase to generate ion gradients that drive
transmitter uptake (Rose et al., 2009a). Glutamate transporters
and Naþ , Kþ-ATPase are part of the same macromolecular com-
plexes and operate as a functional unit to regulate glutamatergic
Fig. 6. Effect of subcutaneous MSG-injection and intragastric treatment with
(PhSe)2 on Ca2þ-ATPase activity in rat hippocampal homogenates. Results are
expressed as nanomole Pi per milligram of protein per minute. Data are reported as
the means7S.E.M for ﬁve to six animals per group. nPo0.05 when compared with
the saline group; #Po0.05 when compared with the MSG group (two-way ANOVA
followed by the Newman–Keuls test).
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neurotransmission in astrocytes and neurons (Rose et al., 2009a;
Zhang et al., 2009).
In addition to Naþ , Kþ-ATPase activity be closely related to
neuronal excitotoxicity, Ca2þ-ATPase plays an important role in
excitotoxic events. The disruption of Ca2þ homeostasis plays a
primary role in the glutamate evoked excitotoxicity (Tymianski
et al., 1993). In this study, neonatal MSG treatment stimulated the
activities of Naþ , Kþ-ATPase and Ca2þ-ATPase, which suggest a
cellular ionic imbalance that corroborates with the decrease of
glutamate uptake induced by MSG, resulting in excitotoxicity. The
stimulation of both ATPases caused by MSG may compensate the
decrease of glutamate uptake. Moreover, (PhSe) reversed the
increase in Naþ , Kþ-ATPase and Ca2þ-ATPase activities, suggesting
that (PhSe)2 antinociceptive action is related to the cellular ionic
concentration maintenance, reversing excitotoxicity caused by MSG.
The current study also demonstrated that MSG increased the
levels of pro-inﬂammatory cytokines (TNF-α, IL-1β, IL-6 and INF-γ)
and decreased those of IL-10, an anti-inﬂammatory cytokine. Cyto-
kines are barely detectable in the CNS under physiological conditions,
but they become rapidly upregulated by pathological events like
neuro inﬂammation and excitotoxicity (Minami et al., 1991). Studies
indicate that pro-inﬂammatory cytokines, particularly IL-1β, increase
neuronal excitability (Bernardino et al., 2005; Vezzani et al., 1999).
Considering that IL-1β can also inhibit glutamate uptake in astrocytes
(Hu et al., 2000), it is plausible to propose that the increase of pro-
inﬂammatory cytokines results in elevated extracellular glutamate
levels. Moreover, TNF-α, IL-1β, IL-6 and INF-γ can also release pro-
inﬂammatory mediators such as: nitric oxide, bradykinin, histamine
and/or substance P at the site of the inﬂammatory process (Morioka
et al., 2002; O'Shaughnessy et al., 2006), contributing to the
emergence and maintenance of pain.
The administration of (PhSe)2 elicited an anti-inﬂammatory
action, characterized by the reduction of pro-inﬂammatory cyto-
kine levels and a tendency (but not statistically signiﬁcant) to
increase the anti-inﬂammatory cytokine in rats treated with MSG.
This is in agreement with previous studies of our research group
that demonstrated that (PhSe)2 protects against the increase of
pro-inﬂammatory cytokines in other experimental model (Luchese
et al., 2012). Other important consideration is that the effect of
(PhSe)2 in decreasing the levels of IL-1 β can be one of the
mechanisms by which this compound normalized the glutamate
uptake in rats treated with MSG. This hypothesis can be supported
by the study of Hu et al. (2000) that demonstrated a link between
IL-1β levels and the inhibition of glutamate uptake. These ﬁndings
Fig. 7. Effect of subcutaneous MSG-injection and intragastric treatment with (PhSe)2 on pro-inﬂammatory cytokine IL-1β (A), TNFα (B), IL-6 (C) and INFγ (D) and anti-
inﬂammatory cytokine (IL-10) levels in rat hippocampal homogenates. Data are reported as the means7S.E.M for four animals per group. nPo0.05 nnnPo0.001 when
compared with the saline group; ##Po0.01; ###Po0.001 when compared with the MSG group (two-way ANOVA followed by the Newman–Keuls test).
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suggest that the anti-inﬂammatory action of (PhSe)2 contributes to
its antinociceptive property in rats administered with MSG.
Furthermore, the results of this study point out that (PhSe)2
reduced excitotoxicity and the levels of pro-inﬂammatory cyto-
kines in the hippocampus, which could contribute to its antino-
ciceptive action.
One limitation of this study is that classical pharmacological
treatments were not tested in this experimental protocol. Thus
although treatment with (PhSe)2 has a potential antinociceptive
and anti-inﬂammatory effects in this model, the obtained results
did not bring a plausible hypothesis about the pathophysiological
mechanisms that lead the MSG-induced nociception.
The results of this study demonstrated that the administration of
MSG induced hippocampal alterations in the [3H]glutamate uptake,
Naþ, Kþ-ATPase and Ca2þ-ATPase activities and in the levels of
cytokines. (PhSe)2 was effective against excitotoxicity and neuroin-
ﬂammation associated to the administration of MSG in rats, indicating
a new role of (PhSe)2 as an antinociceptive compound. Further studies
are needed to better understand the toxicological mechanisms by
which MSG-induced behavioral alterations in rats.
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